Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anaemia Response to the Treatment”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Post-approval studies (Phase 4)UnknownNCT02225886
What this trial is testing

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Who this might be right for
Anaemia Response to the TreatmentPeripheral Iron IndicesOxalemia
Anemia Working Group Romania 100
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Not applicableStudy completedNCT05495607
What this trial is testing

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Who this might be right for
Hypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more
Centre Hospitalier Universitaire de Nice 25
Not applicableStudy completedNCT03310736
What this trial is testing

Serum Hepcidin Immunoassay - Laboratory to Marketplace

Who this might be right for
Anemia, Iron Deficiency
Intrinsic LifeSciences, LLC 494
Post-approval studies (Phase 4)Ended earlyNCT02624141
What this trial is testing

Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Who this might be right for
Anemia
Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Study completedNCT01906489
What this trial is testing

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Akebia Therapeutics 210
Not applicableEnded earlyNCT01736215
What this trial is testing

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Who this might be right for
Anemia - Cancer Related
Janssen-Cilag Ltd.,Thailand 33
Large-scale testing (Phase 3)Active Not RecruitingNCT00843882
What this trial is testing

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Who this might be right for
AnemiaChronic Myelomonocytic LeukemiaDe Novo Myelodysplastic Syndrome+1 more
National Cancer Institute (NCI) 247
Large-scale testing (Phase 3)Study completedNCT00210587
What this trial is testing

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Testing effectiveness (Phase 2)Study completedNCT00086086
What this trial is testing

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

Who this might be right for
Congestive Heart FailureAnemia
Amgen 150
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Not applicableStudy completedNCT01964742
What this trial is testing

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

Who this might be right for
HIV-HCV Co-infected Patients
Assistance Publique Hopitaux De Marseille 68
Testing effectiveness (Phase 2)Study completedNCT00328549
What this trial is testing

Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)

Who this might be right for
Hepatitis CAnemia
Ortho Biotech Products, L.P. 105
Testing effectiveness (Phase 2)Ended earlyNCT05116774
What this trial is testing

BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
BioCryst Pharmaceuticals 12
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Active Not RecruitingNCT05891249
What this trial is testing

Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Who this might be right for
Anemia
Bristol-Myers Squibb 85
Load More Results